ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print June 18, 2009, 10.1183/09031936.00041009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/1148    most recent
09031936.00041009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Vardakas, K. Z.
Right arrow Articles by Falagas, M. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vardakas, K. Z.
Right arrow Articles by Falagas, M. E.
Eur Respir J 2009; 34:1148-1158
Copyright ©ERS Journals Ltd 2009

Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia

K. Z. Vardakas1,2, D. K. Matthaiou1,2 and M. E. Falagas1,3

1 Alfa Institute of Biomedical Sciences (AIBS), Athens, 2 Dept of Medicine, "G. Gennimatas" General Hospital, Thessaloniki, Greece, and 3 Dept of Medicine, Tufts University School of Medicine, Boston, MA, USA.

CORRESPONDENCE: M. E. Falagas, Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23 Marousi, Greece. E-mail: m.falagas{at}aibs.gr

Keywords: Pneumonia, resistance, Staphylococcus aureus

Received: March 12, 2009
Accepted June 5, 2009

We evaluated the published data for the incidence, characteristics and outcomes of patients with community-acquired pneumonia (CAP) due to methicillin-resistant Staphylococcus aureus (MRSA). The estimated incidence of MRSA CAP is 0.51–0.64 cases per 100,000.

We identified 74 articles reporting data on 114 patients. Influenza like symptoms was reported in 41% of patients. Pneumonia improved in 59 (54.1%) out of 109 patients; 49 (44.5%) out of 110 patients died. The duration of hospitalisation was 38.1±24.9 and 8.3±11.7 days, respectively. The duration of intensive care unit (ICU) stay was 18.9±13.6 and 6.8±9.7 days, respectively. 76 strains carried the Panton–Valentine leukocidin gene.

The univariate analysis showed that multi-organ failure (p<0.001), leukopenia (p<0.001), admission to ICU (p<0.001), mechanical ventilation (p<0.001), use of aminoglycosides after culture results (p<0.001), shock (p = 0.001), acute respiratory distress syndrome (p = 0.001), influenza like symptoms (p = 0.008), disseminated intravascular coagulation (p = 0.042) and rash (p = 0.04) were the factors associated with death.




This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Nakou, M. Woodhead, and A. Torres
MRSA as a cause of community-acquired pneumonia
Eur. Respir. J., November 1, 2009; 34(5): 1013 - 1014.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.